Clinical Trials Directory

Trials / Completed

CompletedNCT00937820

Prevention of Recurrence of Venous Thromboembolism in Patients With a History of Venous Thromboembolism

YM150 Long Term Study - Long-term Study in Patients With a History of Venous Thromboembolism

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
87 (actual)
Sponsor
Astellas Pharma Inc · Industry
Sex
All
Age
20 Years
Healthy volunteers
Not accepted

Summary

The study objective is to evaluate the efficacy and safety of oral YM150 for 52 weeks in patients with a history of venous thromboembolism.

Conditions

Interventions

TypeNameDescription
DRUGYM150oral

Timeline

Start date
2009-06-01
Primary completion
2010-12-01
Completion
2010-12-01
First posted
2009-07-13
Last updated
2011-01-06

Locations

5 sites across 1 country: Japan

Source: ClinicalTrials.gov record NCT00937820. Inclusion in this directory is not an endorsement.